Note: Ingredients listed on restricted chemical lists
EC/CAS
202-849-4/100-41-4
Name of the chemical
Ethylbenzene
Concentration
2.5-<10
EC/CAS
216-823-5/1675-54-3
Name of the chemical
2,2'-[(1-methylethylidene)bis(4,1-phenyleneoxymethylene)]bisoxirane
Concentration
N/A
EC/CAS
265-184-9/64742-81-0
Name of the chemical
Kerosine (petroleum), hydrodesulfurized
Concentration
0.1-<1.0
EC/CAS
500-033-5/25068-38-6
Name of the chemical
4,4'-Isopropylidenediphenol, oligomeric reaction products with 1-chloro-2,3-epoxypropane
Concentration
10-<25
EC/CAS
238-877-9/14807-96-6
Name of the chemical
Talc
Concentration
2.5-<10
EC/CAS
77-99-6
Name of the chemical
1,1,1-trimethylolpropane
Concentration
0.1 - <1.0
EC/CAS
262-975-0/61788-44-1
Name of the chemical
Phenol, styrenated
Concentration
0.1-<1.0
EC/CAS
270-966-8/68512-30-1
Name of the chemical
Phenol, methylstyrenated
Concentration
0.1-<1.0
EC/CAS
236-675-5/13463-67-7
Name of the chemical
Reaction mass of titanium dioxide and silver chloride
Concentration
25-<50 10-<25 <=700
EC/CAS
700-960-7
Name of the chemical
Oligomerisation and alkylation reaction products of 2-phenylpropene and phenol
Concentration
N/A
General Information
Product name
8141
supplier name
Tarka, Malgorzata
Manufacturer Name
Carboline Norge AS
Emergency telephone
+1 703 5273887 (Outside US
Icons in SDS
Company Information
company name
Carboline Norge AS
e-mail address of the competent person responsible for the Safety Data Sheet
hms@carboline.com
GHS Information
Signal word
Warning
Hazard Codes
Hazard statements (CLP)
H226, H315, H317, H319, H332, H373, H412
Hazard statements
Code
Statements
H226
Flammable liquid and vapour
Section 2
EU Classification
Classification, Labeling & Packaging Regulation (EC) 1272/2008
Hazard statements
Flammable Liquid, category 3 H226 Skin Irritation, category 2 H315 Skin Sensitizer, category 1 H317 Eye Irritation, category 2 H319 Acute Toxicity, Inhalation, category 4 H332 STOT, repeated exposure, category 2 H373 Hazardous to the aquatic environment, Chronic, H412 category 3 Other EU extensions EUH205 Contains epoxy constituents. May produce an allergic reaction. Other EU extensions EUH211 Warning! Hazardous respirable droplets may be formed when sprayed. Do not breathe spray or mist. Flammable Liquid, category 3 H226 Flammable liquid and vapour. Skin Irritation, category 2 H315 Causes skin irritation. Skin Sensitizer, category 1 H317 May cause an allergic skin reaction. Eye Irritation, category 2 H319 Causes serious eye irritation. Acute Toxicity, Inhalation, category 4 H332 Harmful if inhaled. STOT, repeated exposure, category 2 H373 May cause damage to organs through prolonged or repeated exposure. Hazardous to the aquatic environment, H412 Harmful to aquatic life with long lasting effects. Chronic, category 3
2.2 Label elements
Symbol(s) of Product
Signal word
Warning Named Chemicals on Label ethylbenzene, xylene, poly(bisphenol a-co-epichlorohydrin), glycidyl end-capped, Reaction product: bisphenol-A- (epichlorhydrin) epoxy resin (number average molecular weight <= 700), phenol, methylstyrenated
Precautionary statements
P260 Do not breathe dust/fume/gas/mist/vapours/spray. P280 Wear protective gloves/protective clothing/eye protection/ face protection. P302+352 IF ON SKIN: Wash with plenty of soap and water. P304+340 IF INHALED: Remove victim to fresh air and keep at rest in a position comfortable for breathing. P333+313 If skin irritation or rash occurs: Get medical advice/attention. P337+313 If eye irritation persists: Get medical advice/attention.
2.3 Other hazards
No Information
Results of PBT and vPvB assessment
The product does not meet the criteria for PBT/vPvB in accordance with Annex XIII. Endocrine disrupting properties - Toxicity Based on the available data, the product does not contain substances identified as having endocrine disrupting properties according to Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 in concentration of 0,1% or higher. Endocrine disrupting properties - Ecotoxicity Based on the available data, the product does not contain substances identified as having endocrine disrupting properties according to Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 in concentration of 0,1% or higher.